WayPath Pharma - Crunchbase Company Profile & Funding

Q: Who invested in WayPath Pharma?

WayPath Pharma is funded by National Cancer Institute.

Q: When was the last funding round for WayPath Pharma?

WayPath Pharma closed its last funding round on obfuscated from a Grant round.

Q: How much funding has WayPath Pharma raised to date?

WayPath Pharma has raised obfuscated.

Overview

WayPath Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About WayPath Pharma

CB Rank

192893

WayPath Pharma focuses on chemistry and cancer research.

Founded

obfuscation

Private

Grant

Metairie, Louisiana, United States

1-10

waypathpharma.com/

Oncology

Pharmaceutical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Details

Operating Status

Active

Company Type

For Profit

About the Company

WayPath Pharma focuses on chemistry and cancer research.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PP1

A new class of metabolically active molecules developed as anti-cancer compounds for companion animals, with over 300 variants licensed from LSU.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant
obfuscated obfuscation	Grant - WayPath Pharma	1	obfuscated obfuscation	National Cancer Institute	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Cancer Institute	Yes	Grant - WayPath Pharma	—
National Cancer Institute	Yes	Grant - WayPath Pharma	—
National Cancer Institute	Yes	Grant - WayPath Pharma	—
National Cancer Institute	Yes	Grant - WayPath Pharma	—
National Cancer Institute	Yes	Grant - WayPath Pharma	—